Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT07076550 · Melanoma Metastatic, Uveal Melanoma, Metastatic, and more
NCT06007690 · Choroidal Melanoma, Indeterminate Lesions, and more
NCT06581406 · Metastatic Uveal Melanoma
NCT05607095 · Uveal Melanoma, Melanoma, and more
NCT03947385 · Metastatic Uveal Melanoma, Cutaneous Melanoma, and more
Department of Ophthalmology and Optometry, Medical University Vienna
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions